col blocks we are bridge builder col blocks
COVID answers in Scientific Journals all over the world


195 Results       Page 1

 [1] 
American Association for Cancer Research: Clinical Cancer Research
  original article Date Title Authors   All Authors
1 [GO] 2025―Mar―04 Adoption of Decentralized Trial Elements in Cancer Clinical Trials Supporting FDA Approvals During COVID-19 Timil H. Patel, Amy Corneli, Pamela Balcazar, Craig Lipset, Sara B. Calvert, Sabrena Mervin-Blake, et al. (+2)
2 [GO] 2025―Jan―26 Abstract B002: Pre-vaccine radiation and CTLA-4 blockade increase adjuvant effects of SARS-COV-2 mRNA vaccines Adam Grippin, Sage Copling, Andrew Kim, Elliana Young, Betty Kim, John Heymach, et al. (+2)
3 [GO] 2024―May―17 Abstract B001: Urinary bladder cancer incidence and mortality in the United States: 20-year trends and initial impact of the COVID-19 pandemic Grace B. Gallant, Hugo Pomares-Millan, Judy R. Rees, Margaret R. Karagas, Michael N. Passarelli
4 [GO] 2022―Nov―07 Humoral and cellular immune responses against SARS-CoV-2 after third dose BNT162b2 following double-dose vaccination with BNT162b2 versus ChAdOx1 in cancer patients Yana Debie, Jonas R.M. Van Audenaerde, Timon Vandamme, Lieselot Croes, Laure-Anne Teuwen, Lise Verbruggen, et al. (+16)
5 [GO] 2022―Feb―09 AACR Report on the Impact of COVID-19 on Cancer Research and Patient Care Patrick A. Williams, Sayyed Kaleem Zaidi, Rajarshi Sengupta
6 [GO] 2021―Sep―28 Immunogenicity and safety of COVID-19 vaccine BNT162b2 for patients with solid cancer: a large cohort prospective study from a single institution. Vincenzo Di Noia, Fulvia Pimpinelli, Davide Renna, Vittoria Barberi, Maria Teresa Maccallini, Ludovica Gariazzo, et al. (+18)
7 [GO] 2021―Jun―09 A Neoadjuvant Chemotherapy Trial for Early Breast Cancer is Impacted by COVID-19: Addressing Vaccination and Cancer Trials Through Education, Equity, and Outcomes David A. Potter, Alexandra Thomas, Hope S. Rugo
8 [GO] 2021―Mar―12 Abstract P30: Long-term outcomes of cancer patients infected with COVID-19 Justin Shaya, Angelo Cabal, Pedram Razavi, Rana R. McKay
9 [GO] 2021―Mar―12 Abstract P22: A high-throughput anti-SARS-CoV-2 IgG testing platform for COVID-19 Jinwei Du, Eric Chu, Dayu Zhang, Chuanyi M. Lu, Aiguo Zhang, Michael Sha
10 [GO] 2021―Mar―12 Abstract P08: Adenosine-based cancer immunotherapy for COVID-19 Giulia Monticone, Alistair Ramsay, Lucio Miele
11 [GO] 2021―Mar―12 Abstract P12: Colorectal cancer screening in Appalachian Kentucky primary care clinics during COVID-19 Aaron J. Kruse-Diehr, Mark Cromo, Melinda Rogers, Angela Carman, Bin Huang, David Gross, et al. (+3)
12 [GO] 2021―Mar―12 Abstract P41: Mental health and coping during COVID-19 among cancer patients and survivors Jeanine P.D. Guidry, Carrie A. Miller, Bernard F. Fuemmeler
13 [GO] 2021―Mar―12 Abstract S11-02: Factors associated with developing COVID-19 among cancer patients in New York City Monica F. Chen, Monica T. Coronel, Samuel Pan, Arreum Kim, Jessica Hawley, Gary Schwartz, Katherine Crew
14 [GO] 2021―Mar―12 Abstract S09-04: Asymptomatic detection of COVID-19 among cancer patients receiving infusional anti-cancer therapy Justin A. Shaya, Angelo Cabal, Francesca Torriani, Joseph Califano, Scott Lippman, Assuntina Sacco, Rana R. McKay
15 [GO] 2021―Mar―12 Abstract S09-02: High incidence of persistent COVID-19 among patients with lymphoma treated with B-cell depleting immunotherapy Sylvain Lamure, Remy Dulery, Marc Delord, Roberta Di Blasi, Adrien Chauchet, Thomas Hueso, et al. (+19)
16 [GO] 2021―Mar―12 Abstract P24: Evidenced-based natural therapies and immune-enhancing strategies to control, prevent, and treat co-morbidities COVID-19 and cancer Padma P. T. Uppala, Sherri Isaak, Brian Wong, Kimberly Ferreira, Carlos Garberoglio, John Kelly
17 [GO] 2021―Mar―12 Abstract S06-02: Disruption to care of patients with thoracic malignancies: A COVID-19 and cancer outcomes study Sheena Bhalla, Ziad Bakouny, Andrew L. Schmidt, John A. Steinharter, Douglas A. Tremblay, Mark M. Awad, et al. (+24)
18 [GO] 2021―Mar―12 Abstract P25: Prostate cancer and COVID-19 outcomes: Results from the Cleveland Clinic registry of COVID-19 and cancer patients Scott J. Dawsey, Nathan A. Pennell, Christopher Lemmon, Amanda Nizam, Wei Wei, Timothy D. Gilligan, et al. (+2)
19 [GO] 2021―Mar―12 Abstract S11-04: Using CXR-Net to detect COVID-19 and non-COVID-19 patients Benjamen Huber, Abdulah Haikal, Domenico Gatti, Hamid Soltanian-Zadeh
20 [GO] 2021―Mar―12 Abstract S10-03: Adolescent and young adult cancer patient and survivor employment changes during COVID-19 are associated with financial toxicity Austin Waters, Heydon Kaddas, Karely Mann, Perla L. Vaca Lopez, Echo L. Warner, Joemy Ramsay, et al. (+9)
21 [GO] 2021―Mar―12 Abstract P23: Detection of humoral and cellular responses to SARS-CoV-2 in COVID-19 convalescents Anna Baranska, Marc Schuster, Marek Wieczorek, Sebastian Flade, Lennart Wessels, Burhan Karaca, et al. (+3)
22 [GO] 2021―Mar―12 Abstract S12-03: Clinical and demographic characteristics associated with shorter time to COVID-19 death Maria J. Monroy-Iglesias, Beth Russell, Charlotte Moss, Gincy George, Kieran Palmer, Sophie Papa, et al. (+35)
23 [GO] 2021―Mar―12 Abstract S12-04: COVID-19 disease in patients with lung cancer in Spain: GRAVID Lung Cancer Patients Disease (GRAVID study) Jose Maria Mazarico Gallego, Antonio Calles, Monica Antoñanzas, Cristina Pangua, Xabier Mielgo Rubio, Ernest Nadal, et al. (+16)
24 [GO] 2021―Mar―12 Abstract P06: Anticancer agent 3-deazauridine has the potential to be effective against COVID-19 due to its inhibition of replication of RNA viruses Richard Momparler
25 [GO] 2021―Mar―12 Abstract S12-06: Social Determinants of Health (SDOH) barriers as predictors of intent to vaccinate for COVID-19 in a vulnerable population Beth A. Jones, William Eger, Sakinah Suttiratana, Roy Herbst, Eiman Ibrahim, Hannah Behringer, Rachel A. Clare
26 [GO] 2021―Mar―12 Abstract S12-05: Prevalence of COVID-19 in asymptomatic cancer patients on active systemic treatment in a public Brazilian hospital: The impact of socioeconomic status Luiza Fadul, Barbara Benetton, Larissa Furlan, Marina Topanotti, Marcia Lanza, Mauricio Nogueira, et al. (+2)
27 [GO] 2021―Mar―12 Abstract P11: The elevated level of the main markers of neutrophil extracellular traps in metastatic colorectal cancer plasma highlights the enhanced risk of severe forms of COVID-19 in cancer patients Alain R. Thierry, Brice Pastor, Jean-Daniel Abraham, Ekaterina Pisareva, Thibault Mazard
28 [GO] 2021―Mar―12 Abstract P33: Disparities in breast cancer screening and the impact of COVID-19 in Houston, Texas Maryam Nemati Shafaee, Luke Gilman, Abiodun Oluyomi, Melissa Bondy, Tamara Ortiz-Perez, Chris Amos, Mothaffar Rimawi
29 [GO] 2021―Mar―12 Abstract S06-03: Outcomes of COVID-19 in patients with cancer: Results of a prospective observational comparison of routine screening strategy versus testing based on clinical suspicion Zhuoer Xie, Antoine N. Saliba, Jithma Abeykoon, Umair Majeed, Daniel Almquist, Julia Wiedmeier-Nutor, et al. (+20)
30 [GO] 2021―Mar―12 Abstract S11-03: The impact of COVID-19 in the cancer population stratified by age: A real-world data study from Guy’s Cancer Center Rushan Sylva, Beth Russell, Charlotte Moss, Gincy George, Kieran Palmer, Vallari Shah, et al. (+14)
31 [GO] 2021―Mar―12 Abstract P43: Clinical characteristics of COVID-19 infected cancer patients: A retrospective study in Royal Wolverhampton NHS Trust, United Kingdom Menna M. Fouda, Ankit Jain
32 [GO] 2021―Mar―12 Abstract P42: Construction of a risk map to understand the vulnerability of various types of cancer patients to COVID-19 infection Jian He, Mei Meng, Yiyang Zhao
33 [GO] 2021―Mar―12 Abstract P28: COVID-19 infection and mortality in patients with skin malignancies receiving systemic anti-cancer therapy (SACT): The Guy’s Cancer Centre experience Lucy Flanders, Beth Russell, Charlotte Moss, Kieran Palmer, Rushan Sylva, Gincy George, et al. (+14)
34 [GO] 2021―Mar―12 Abstract S12-02: Comprehensive meta-analysis of COVID-19 mortality rates for 22 cancer subtypes from the Reboot: COVID-Cancer Project, an interactive resource with aggregated data from 21,839 cancer patients Emily-Claire Duffy, Kelly Fan, Shailesh Advani, Chris Bailey, James R.M. Black, Ellie Strauss, et al. (+9)
35 [GO] 2021―Mar―12 Abstract S12-01: Quantifying the impact of COVID-19 on cancer care: Pathology volume change in SEER cancer registries Todd Golden, Linda Coyle, Jennifer Stevens, Serban Negoita
36 [GO] 2021―Mar―12 Abstract P05: EpistoNet: An ensemble of deep convolutional neural networks using mixture of discriminative experts for detecting COVID-19 on chest X-ray images Seyed Ziae Mousavi Mojab, Seyedmohammad Shams, Farshad Fotouhi, Hamid Soltanian-Zadeh
37 [GO] 2021―Mar―12 Abstract P44: Factors affecting COVID-19 outcomes in cancer patients from Guy’s Cancer Center and King's College Hospital Kieran Palmer, Rushan Sylva, Beth Russell, Charlotte Moss, Vallari Shah, Thinzar Ko Ko, et al. (+22)
38 [GO] 2021―Mar―12 Abstract S06-04: Telehealth experiences of adolescent and young adult cancer patients and survivors during the COVID-19 pandemic Karely Mann, Austin R. Waters, Perla L. Vaca Lopez, Echo L. Warner, Judy Ou, Heydon Kaddas, et al. (+9)
39 [GO] 2021―Mar―12 Abstract P40: PTSD and levels of general anxiety in Italian oncological patients during the COVID-19 pandemic Mariam Chichua, Eleonora Brivio, Serena Oliveri, Paolo Guiddi, Gabriella Pravettoni
40 [GO] 2021―Mar―12 Abstract S02-04: Drive By Flu-FIT: A novel way to mitigate the decrease in colorectal cancer screening during the COVID-19 pandemic Armenta Washington, Leroy Miles, Claudia Melendez, Brenda Bryant, Alexander Auchus, Michael Goldberg, et al. (+5)
41 [GO] 2021―Mar―12 Abstract S10-04: Disparities in food insecurity among cancer survivors during the U.S. COVID-19 pandemic Marlene Camacho-Rivera, Jessica Y. Islam, Denise C. Vidot
42 [GO] 2021―Mar―12 Abstract P27: Effect of paclitaxel in gefitinib-resistant non-small cell lung cancer (NSCLC) treatment during the COVID-19 pandemic Md Mohiuddin, Kazuo Kasahara
43 [GO] 2021―Mar―12 Abstract S04-02: Effects of demographic and behavioral factors on social isolation in a cancer center population during COVID-19 pandemic Cassandra A. Hathaway, Brian D. Gonzalez, Amanda Bloomer, Erin M. Siegel, Cornelia M. Ulrich, Anita R. Peoples, et al. (+2)
44 [GO] 2021―Mar―12 Abstract P17: Effect of telemedicine adoption on accessibility and time to treatment in patients with thoracic malignancies during the COVID-19 pandemic Vivek U. Nimgaonkar, Abigail T. Berman, Peter Gabriel, John Kucharczuk, Lawrence N. Shulman, Charu Aggarwal, Melina E. Marmarelis
45 [GO] 2021―Mar―12 Abstract S02-02: The impact of resuming the breast cancer screening program in the Netherlands on breast cancer incidence and stage after its discontinuation due to the COVID-19 pandemic Anouk H. Eijkelboom, Linda de Munck, Marc B.I. Lobbes, Jelle Wesseling, Carla H. van Gils, Pieter J. Westenend, et al. (+5)
46 [GO] 2021―Mar―12 Abstract P36: Virtual cancer care in a tertiary care academic centre in Ireland during the COVID-19 pandemic - An analysis of physician and patient opinion Mary N. O'Reilly, Mark Doherty
47 [GO] 2021―Mar―12 Abstract S09-03: Real world data analysis of patients with genitourinary cancers receiving systemic anticancer treatment during the COVID-19 pandemic at Guy's Cancer Centre: A single centre retrospective study in the UK Christina Karampera, Beth Russell, Charlotte Moss, Rushan Sylva, Kieran Palmer, Elias Pintus, et al. (+6)
48 [GO] 2021―Mar―12 Abstract P19: Systemic anticancer treatment changes at the start of the COVID-19 pandemic in a large Australian metropolitan health service Elizabeth Liow, Cameron McLaren, Samuel Tipping-Smith, Sarah Latham, Jun Beng Kong, Marissa Lam, et al. (+4)
49 [GO] 2021―Mar―12 Abstract P15: Treatment (TX) of advanced melanoma during the Coronavirus Disease 2019 (COVID-19) pandemic in Kaiser Permanente Northern California (KPNC) Juraj Kavecansky, Nina Shah, Angeles Price, Frank Hsieh, Alice Kengla, Belinda Ark, et al. (+12)
50 [GO] 2021―Mar―12 Abstract S02-03: The impact of the COVID-19 pandemic on Barrett’s esophagus and esophago-gastric cancer Richard C. Turkington, Anita Lavery, David Donnelly, Anna T. Gavin, Damian T. McManus, Victoria Cairnduff, et al. (+4)
51 [GO] 2021―Mar―12 Abstract P45: A global snapshot of the impact of the COVID-19 pandemic on cancer research: Report from a Global Cancer and COVID-19 Task Force Louis Fox, Verna Vanderpuye, Richard Sullivan, Mieke Van Hemelrijck, Deborah Mukherji
52 [GO] 2021―Mar―12 Abstract S04-03: Impact of the COVID-19 pandemic on social and health behaviors among rural and urban cancer patients at Huntsman Cancer Institute (HCI) Bailee Daniels, Caroline Himbert, Cassandra A. Hathway, Tengda Lin, Karen Salas, Anjelica Ashworth, et al. (+22)
53 [GO] 2021―Mar―12 Abstract P32: Inequalities in the decline and recovery of pathological cancer diagnoses during the first six months of the COVID-19 pandemic: A population-based study Ashleigh C. Hamilton, David W. Donnelly, Maurice B. Loughrey, Richard C. Turkington, Colin Fox, Deirdre Fitzpatrick, et al. (+3)
54 [GO] 2021―Mar―12 Abstract S10-02: Financial hardship and mental health among cancer survivors during the COVID-19 pandemic: An analysis of the U.S. COVID Impact Survey Jessica Y. Islam, Denise C. Vidot, Marlene Camacho-Rivera
55 [GO] 2021―Mar―12 Abstract P02: Predicting mortality in SARS-CoV-2 (COVID-19) positive patients in the inpatient setting using a Novel Deep Neural Network Fahad S. Ahmed, Maleeha Naseem, Hajra Arshad, Syeda Amrah Hashmi, Furqan Irfan
56 [GO] 2021―Mar―12 Abstract P26: Re-analyzing randomized trials with incorporation of COVID-19 risk associated with cancer therapy Shervin Tabrizi, Lorenzo Trippa, Daniel Cagney, Ayal A. Aizer, Shyam Tanguturi, Steffen Ventz, et al. (+8)
57 [GO] 2021―Mar―12 Abstract P04: Effects of COVID-19 treatments on cancer: A machine learning approach to synthesize clinical evidence at scale Allison Britt, Emily Yang, Devon Crittenden, Thomas Bhangdia, Ben Nye, Emily-Claire Duffy, et al. (+15)
58 [GO] 2021―Mar―12 Abstract S05-02: Plant viral nanoparticle-based adjuvants for cancer immunotherapy and COVID-19 vaccines Nicole F. Steinmetz, Jonathan K. Pokorski, Steven N. Fiering, P. Jack Hoopes, Sourabh Shukla, Oscar A. Ortega-Rivera, et al. (+2)
59 [GO] 2021―Mar―12 Abstract P38: An examination of COVID-19-related preventive behaviors by cancer status Carrie A. Miller, Jeanine P.D. Guidry, Bernard F. Fuemmeler
60 [GO] 2021―Mar―12 Abstract P34: Health care disparities and outcomes of cancer patients with COVID-19: A pooled analysis of two Brazilian tertiary centers Marina Topanotti, Larissa L. Furlan, Catarina Marchon, Pedro Amaral, Barbara C. Beneton, Luiza A. Fadul, et al. (+5)
61 [GO] 2021―Mar―12 Abstract P18: Radical cancer treatment is safe during COVID-19: The experience of a large London-based Comprehensive Cancer Centre Beth Russell, Victoria Harris, Harvey Dickinson, Charlotte Moss, Graham Roberts, Kate Haire, et al. (+15)
62 [GO] 2021―Mar―12 Abstract P20: Continuity of oncology clinical trials during the Coronavirus Disease-2019 pandemic in Korea Hee Kyung Ahn, Soohyeon Lee, Seon-A Jang, Ji-Yeon Kim, Jin Seok Ahn, Yeon Hee Park
63 [GO] 2021―Mar―12 Abstract S03-04: Spatial profiling of lung SARS-CoV-2 and influenza virus infection identifies virus specific host responses and gene signatures Arutha Kulasinghe
64 [GO] 2021―Mar―12 Abstract P21: Saliva as a testing specimen with or without pooling for SARS-CoV-2 detection by multiplex RT-PCR test Qing Sun, Jonathan Li, Hui Ren, Larry Pastor, Yulia Loginova, Joseph Wong, et al. (+4)
65 [GO] 2021―Mar―12 Abstract S03-02: Adaptive immunity to SARS-CoV-2 in cancer patients: The CAPTURE study Lewis Au, Annika Fendler, Laura Amanda Boos, Fiona Byrnes, Scott Shepherd, Emma Nicholson, et al. (+9)
66 [GO] 2021―Mar―12 Abstract S03-03: Cancer patients display diminished viral RNA clearance and altered T cell responses during SARS-CoV-2 infection Michael Chiorazzi, Erin Silva, Kristina Brower, Patrick Wong, Carolina Lucas, Jon Klein, et al. (+25)
67 [GO] 2021―Mar―12 Abstract S01-03: The acute phase response identifies cancer patients with adverse outcomes from SARS-CoV-2 infection as quantified by the OnCovid Inflammatory Score Gino M. Dettorre, Saoirse Dolly, Angela Loizidou, John Chester, Amanda Jackson, Uma Mukherjee, et al. (+44)
68 [GO] 2021―Mar―12 Abstract S01-02: Assessing vulnerability of patients with lung cancer to SARS-CoV-2 infection based on serological antibody analyses Amy C. Moore, Paul A Bunn, Beatriz Fontoura, Adolfo García-Sastre, Jorge Gomez, Florian Krammer, et al. (+6)
69 [GO] 2021―Mar―12 Abstract P35: Targeting vimentin impacts multiple cellular processes, blocks the spike protein-ACE2-mediated pseudoviral infection in vitro and reduces the symptom and lung injury in aged mice with mouse-adapted SARS-CoV-2 infection in vivo Zhizhen Li, Jianping Wu, Baoshi Yuan, Kenneth Dinnon, Lian Mo, Fei Zhou, et al. (+6)
70 [GO] 2021―Mar―12 Abstract P13: Prospective voluntary SARS-CoV-2 virus and anti-COVID-19 antibody tests in asymptomatic medical and research staff who work in direct contact with cancer patients: A single center study Weijing Sun, Andrew K. Godwin, Kathan Mehta, Natalie Streeter, Elizabeth Wulff-Burchfield, Anup Kasi, et al. (+8)
71 [GO] 2021―Mar―12 Abstract P29: Pre-COVID-19 pandemic vs. post-COVID-19 pandemic: Sustained participation of minorities in research in a CAP accredited biorepository in UC San Diego, California Sharmeela A. Kaushal, David Anjakos, Mason A. Kyle, Diana Cortez-Moreno, Alfredo A. Molinolo
72 [GO] 2021―Mar―01 Vascular normalization to improve treatment of COVID-19: Lessons from treatment of cancer Lance L Munn, Triantafyllos Stylianopoulos, Natalie K Jain, C Corey Hardin, Melin J Khandekar, Rakesh K. Jain
73 [GO] 2021―Feb―04 How did we get a COVID-19 vaccine in less than one year? E. John Wherry, Elizabeth M. Jaffee, Nicholas Warren, Gypsyamber D'Souza, Antoni Ribas
74 [GO] 2020―Dec―03 Abstract S01-01: Therapeutic targeting of TMPRSS2 and ACE2 as a potential strategy to combat COVID-19 Qu Deng, Reyaz Ur Rasool, Ramakrishnan Natesan, Irfan A. Asangani
75 [GO] 2020―Dec―03 Abstract PO-069: SRMS correlated with immune infiltration and lung cancer: Allusion for COVID-19 Beesetti Swarna, Yong-Dong Wang, Malia B. Potts
76 [GO] 2020―Dec―03 Abstract PO-032: Patient-centered communication: Collaborative learning and communication strategies for patients and health care providers in the new normal of COVID-19 Martha Raymond, Margaret-Ann Simonetta
77 [GO] 2020―Dec―03 Abstract PO-011: CiRCL: A psychosocial program facilitating communication and care to patients, families, and frontline health care teams during COVID-19 Kauser Ahmed, Peter Phung, Noah Goldstein, John Glaspy
78 [GO] 2020―Dec―03 Abstract PO-012: Clinical features and antibody response of two pediatric patients presenting with new-onset acute myeloid leukemia and concomitant severe COVID-19 Pratik A. Patel, Christina A. Rostad, Stacey A. Lapp, Claire L. Stokes, Melinda G. Pauly, Evan J. Anderson, Himalee S. Sabnis
79 [GO] 2020―Dec―03 Abstract S10-02: Using real-world data (RWD) from an integrated platform for rapid analysis of patients with cancer with and without COVID-19 across distinct health systems Shirish M. Gadgeel, Michael A. Thompson, Monika A. Izano, Clara Hwang, Tom Mikkelsen, James L. Weese, et al. (+7)
80 [GO] 2020―Dec―03 Abstract S06-01: Changes implemented by U.S. oncology practices in response to COVID-19 pandemic: Initial report from the ASCO Registry on COVID-19 and cancer Suanna S. Bruinooge, Elizabeth Garrett-Mayer, Stephen Meersman, Patricia Hurley, Brian Bourbeau, Allyn Moushey, et al. (+4)
81 [GO] 2020―Dec―03 Abstract IA26: Understanding the impact of COVID in cancer patients through the COVID-19 and Cancer (CCC-19) and other COVID consortiums Brian I. Rini
82 [GO] 2020―Dec―03 Abstract PO-061: Data harmonization for COVID-19 and cancer research registries Rimma Belenkaya, Adam Watson, Shantha Bethusamy, Meera Patel, Tatyana Sandler, Julian Schwartz, et al. (+6)
83 [GO] 2020―Dec―03 Abstract PO-091: CAPTURE: Cancer and COVID-19 antiviral immune monitoring study Annika Fendler, Laurie Boos, Lewis Au, Scott Shepherd, Fiona Byrne, Kim Edmonds, et al. (+7)
84 [GO] 2020―Dec―03 Abstract PO-019: Impact of a hospital conversion to COVID-19 center on cancer care of patients in a urologic oncology clinic in Mexico Salvador G. Santiesteban, Haydee Verduzco-Aguirre, Christianne Bourlon, Maria T. Bourlon
85 [GO] 2020―Dec―03 Abstract S12-03: Thoracic cancers international COVID-19 collaboration (TERAVOLT): Small-cell lung cancer and other rare thoracic malignancies Alessio Cortellini, Anne-Marie C. Dingemans, Oscar Arrieta, Javier Baena, Matteo Brighenti, Enriqueta Felip, et al. (+19)
86 [GO] 2020―Dec―03 Abstract IA20: Potential insights into COVID-19 disparities from the science of cancer health disparities John M. Carethers
87 [GO] 2020―Dec―03 Abstract S09-04: Unemployment and cancer screening: Baseline estimates to inform health care provision in the context of COVID-19 economic distress Stacey A. Fedewa, K. Robin Yabroff, Zhiyuan Zheng, Priti Bandi, Ann Goding Sauer, Robert A. Smith, et al. (+3)
88 [GO] 2020―Dec―03 Abstract PO-005: Barriers to implementation of virtual collection of patient-reported data in the COVID-19 era Karineh Kazazian, Wendy Johnston, Jessica Bogach, Carol J. Swallow
89 [GO] 2020―Dec―03 Abstract PO-042: Would dermoscopic photographs help triage teledermatology consults in the COVID-19 era? Myles R. McCrary, Tova Rogers, Howa Yeung, Loren Krueger, Suephy C. Chen
90 [GO] 2020―Dec―03 Abstract PO-036: Safety outcomes of resuming anticancer treatment in patients with lung cancer affected by COVID-19 illness Antonio Calles, Mar Galera, Inmaculada Aparicio, Manuel Alva, Marianela Bringas, Natalia Gutierrez, et al. (+3)
91 [GO] 2020―Dec―03 Abstract PO-027: Multi-institutional survey of COVID-19 impact in cancer care in patients and health care providers Sylvia V. Alarcon, Omid Salehi, Eduardo A. Vega, Vera Kazakova, Claudius Conrad
92 [GO] 2020―Dec―03 Abstract S07-01: Examining COVID-19 preventive behaviors among cancer survivors in the United States: An analysis of the COVID-19 Impact Survey Jessica Y. Islam, Marlene Camacho-Rivera, Denise C. Vidot
93 [GO] 2020―Dec―03 Abstract PO-062: Early impact of COVID-19 in cancer care: The experience of a Brazilian outpatient clinic Cinthya Sternberg, Bianca Vivas, Thamine Lessa Andrade, Ana Paula Vila Nova, Ana Paula Fernandes, Camila Alves, et al. (+7)
94 [GO] 2020―Dec―03 Abstract S02-01: Clinical characteristics and outcomes of coronavirus 2019 disease (COVID-19) in cancer patients treated with immune checkpoint inhibitors (ICI) Aljosja Rogiers, Carlo Tondini, Joe M. Grimes, Megan H. Trager, Sharon Nahm, Leyre Zubiri, et al. (+19)
95 [GO] 2020―Dec―03 Abstract PO-021: Impact of COVID-19 in continuity of cancer treatment for lung cancer patients Antonio Calles, Manuel Alva, Inmaculada Aparicio, Javier Soto, Natalia Gutierrez, Marianela Bringas, et al. (+4)
96 [GO] 2020―Dec―03 Abstract PO-060: COVID-CANCER HUIL STUDY: Registry of oncologic patients diagnosed with Covid-19 in Infanta Leonor University Hospital in Madrid, Spain Jacobo Rogado, Berta Obispo, Gloria Serrano-Montero, Almudena Martin Merino, Ana Lopez-Alfonso, Cristina Pangua, et al. (+3)
97 [GO] 2020―Dec―03 Abstract PO-059: COVID-19 in melanoma patients: Spanish register Maria Gonzalez-Cao, Cristina Carrera, Juan Francisco Rodriguez Moreno, Pedro Rodriguez-Jiménez, Mónica Antoñanzas Basa, Marta Feito Rodríguez, et al. (+19)
98 [GO] 2020―Dec―03 Abstract S04-01: Famotidine use and quantitative symptom tracking for COVID-19 in nonhospitalized patients: A case series Tobias Janowitz, Eva C. Gablenz, David J. Pattinson, Timothy C. Wang, Joseph Conigliaro, Kevin J. Tracey, David A. Tuveson
99 [GO] 2020―Dec―03 Abstract PO-028: One piece of the jigsaw for the cancer recovery strategy: Prevalence of COVID-19 in patients with cancer Charlotte Moss, Beth Russell, Mary Lei, Sharmista Ghosh, Sophie Papa, Richard Sullivan, et al. (+2)
100 [GO] 2020―Dec―03 Abstract PO-031: Outcomes of COVID-19 in patients with lung cancer treated in a tertiary hospital in Madrid Antonio Calles, Inmaculada Aparicio, Manuel Alva, Marianela Bringas, Natalia Gutierrez, Javier Soto, et al. (+2)
101 [GO] 2020―Dec―03 Abstract IA04: COVID-19 in patients with lung cancers in New York City Jia Luo, Hira Rizvi, Isabel R. Preeshagul, Jacklynn V. Egger, David Hoyos, Chaitanya Bandlamudi, et al. (+6)
102 [GO] 2020―Dec―03 Abstract PO-035: Public social media discussion of COVID-19 in relation to cancer services disruption Damian Eade, Laura Galimam, Mónica Fernández-Sierra, Caryn Gordon, Jason McDonough
103 [GO] 2020―Dec―03 Abstract PO-079: COVID-19 in relation to hematologic events and mortality in subset of inpatient cancer patients Saikrishna Gadde, Ambuga Badari, John Cole, Nikhil Manjunath
104 [GO] 2020―Dec―03 Abstract PO-086: Covid-19 in the city of Teofilo Otoni-Minas Gerais: Current panorama and future perspectives Laryssa Reis Coelho, Gustavo da Mata Oliveira Rezende, Virgílio Barroso de Aguiar, Vânia Soares Oliveira e Almeida Pinto, Rafael Genaro, Rafael Alvarenga Almeida, et al. (+7)
105 [GO] 2020―Dec―03 Abstract S09-01: Cancer and race: Two important risk factors for COVID-19 incidence as captured by the COVID Symptom Study real-time epidemiology tool David A. Drew, Long H. Nguyen, Wenjie Ma, Chun-Han Lo, Amit D. Joshi, Daniel Sikavi, et al. (+6)
106 [GO] 2020―Dec―03 Abstract PO-020: Impact of CDK 4/6i withdrawal or dose adjustment on COVID-19 incidence in HR+/HER2- mBC patients during the pandemic Pablo Tolosa, Ana Sanchez-Torre, Helena Bote de Cabo, Rodrigo Sánchez-Bayona, Mercedes Herrera, Ramón Yarza, et al. (+3)
107 [GO] 2020―Dec―03 Abstract PO-081: Outcomes of patients with multiple myeloma with COVID-19 infection Michael John Lunski, Karine Tawagi, Diana Maslov, Laura Finn
108 [GO] 2020―Dec―03 Abstract PO-067: Tissue banking from patients with SARS-CoV-2 (COVID-19) infection Emily F. Higgs, Blake A. Flood, Athalia R. Pyzer, Sherin J. Rouhani, Jonathan A. Trujillo, Kyle R. Cron, et al. (+8)
109 [GO] 2020―Dec―03 Abstract PO-025: Management of breast cancer surgery during de-escalation of COVID-19 infection Juana María Brenes Sánchez, Amanda López Picado, María Eugenia Olivares Crespo, José Ángel García Sáenz, Rosa María De La Plata Merlo, María Herrera De La Muela
110 [GO] 2020―Dec―03 Abstract S12-01: High mortality among hospital-acquired COVID-19 infection in patients with cancer: An observational cohort study from Q and British Columbia Arielle Elkrief, Antoine Desilets, Neha Papneja, Lena Cvetkovic, Catherine Groleau, Yahia Abdelali Lakehal, et al. (+18)
111 [GO] 2020―Dec―03 Abstract PO-078: Clinical characteristics and outcomes of cancer patients with COVID-19 infection: A retrospective study in a single center in the Philippines Jessa Gilda P. Pandy, Michelle Joane Alcantara, Frances Victoria Que, Marie Belle Francia
112 [GO] 2020―Dec―03 Abstract PO-071: Collaborating to share evidence-based COVID-19 information across lung cancer patient advocacy groups Amy C. Moore, Janet Freeman-Daily, Kim Norris, Becky Bunn, Jan Baranski, Cristina Chin, Upal Basu Roy
113 [GO] 2020―Dec―03 Abstract PO-051: Intracellular delivery of nuclear localization signal suppresses COVID-19 mediated inflammation by regulating expression of cytokines/chemokines Danbi Lee, Sanghyeon Yu, Misuk Baek, Jieun Kim, Mingu Kang, Hakyoung Park, et al. (+14)
114 [GO] 2020―Dec―03 Abstract PO-070: What kills patients with severe Covid-19 might also kill patients with terminal cancer Lingbing Zhang
115 [GO] 2020―Dec―03 Abstract S11-03: Impact of COVID-19 on breast and prostate cancer screening and early detection in a large health care provider group Mara M. Epstein, Devi Sundaresan, Meagan Fair, Lawrence Garber, Mary Charpentier, Jerry H. Gurwitz, Terry S. Field
116 [GO] 2020―Dec―03 Abstract PO-016: Evaluating the impact of COVID-19 on medical oncology workforce and cancer care in Canada: A serial survey study Sharlene Gill, Bruce Colwell, Hal Hirte, Welch Stephen, Alexi Campbell, Desiree Hao
117 [GO] 2020―Dec―03 Abstract PO-089: The impact of Covid-19 on public generosity toward cancer-related crowdfunding efforts Katrina A. Fischer, Robert E. Miller, Sidharth Anand, John Glaspy
118 [GO] 2020―Dec―03 Abstract S07-02: Patient-reported outcomes of breast cancer patients during the COVID-19 outbreak in the epicenter of China: A cross-sectional survey study Juanjuan Li, Cesar Augusto Santa-Maria, Hongfang Feng, Lingcheng Wang, Pengcheng Zhang, Yuangbing Xu, et al. (+10)
119 [GO] 2020―Dec―03 Abstract PO-007: Breast cancer management during COVID-19 outbreak: Learned lessons Juana María Brenes Sánchez, Amanda López Picado, José Ángel García Sáenz, María Eugenia Olivares Crespo, Rosa María De La Plata Merlo, María Herrera De La Muela
120 [GO] 2020―Dec―03 Abstract S09-03: Factors affecting COVID-19 outcomes in cancer patients: A first report from Guy’s Cancer Centre in London Beth Russell, Charlotte Moss, Sophie Papa, Sheeba Irshad, Paul Ross, James Spicer, et al. (+18)
121 [GO] 2020―Dec―03 Abstract PO-056: Using MammaPrint to reduce the need for chemotherapy in early breast cancer during the COVID-19 pandemic Elizabeth M. Murray, Ettienne J. Myburgh, Ersan Lujinovic, Lorenza Mittempergher, Duncan J. Robertson, Josephus J. de Jager, Maritha J. Kotze
122 [GO] 2020―Dec―03 Abstract PO-065: National Clinical Trials Network biobanking during the COVID-19 pandemic Heather A. Lankes, Mark A. Watson, Richard C. Jordan, Nilsa C. Ramirez, Ignacio I. Wistuba, Lois Shepherd, et al. (+2)
123 [GO] 2020―Dec―03 Abstract PO-009: Cancer-related distress among multiple myeloma patients during the COVID-19 pandemic Nathan W. Sweeney, Jenny Ahlstrom
124 [GO] 2020―Dec―03 Abstract IA16: COVID-19 pandemic and its effect on the psychological status of cancer patients and oncologists Gabriella Pravettoni
125 [GO] 2020―Dec―03 Abstract PO-087: COVID-19 pandemic in Italy: Social distress and gender imbalance among health care professionals Rossana Berardi, Mariangela Torniai, Maria Silvia Cona, Fabiana Cecere, Rita Chiari, Valentina Guarneri, et al. (+5)
126 [GO] 2020―Dec―03 Abstract PO-008: Cancer care during the COVID-19 pandemic in Southern India Anita Ramesh, Raji Ssoundarajan
127 [GO] 2020―Dec―03 Abstract S11-02: Patient-reported impact of the COVID-19 pandemic on breast cancer screening, diagnosis, and treatment: A national survey Erica T. Warner, Emily Restrepo, Christine Benjamin, Ricki Fairley, Laura Roudebush, Leah Eshraghi, et al. (+3)
128 [GO] 2020―Dec―03 Abstract PO-040: The Effects of the COVID-19 pandemic on cancer patient encounters Jack W. London, Elnara Fazio-Eynullayeva, Matvey Palchuk, Corinna Mossop, Peter Sankey, Christopher McNair
129 [GO] 2020―Dec―03 Abstract PO-041: The impact of the COVID-19 pandemic on cancer patients Lola Rahib, Zach Kaufman, Erika Vial Monteverdi
130 [GO] 2020―Dec―03 Abstract S11-01: Assessing the impact of the COVID-19 pandemic on cancer patients, survivors, and caregivers Amy Leader, Preethi Selvan, Lisa Capparella, Rebecca Cammy, Janene Palidora, Ayako Shimada, et al. (+3)
131 [GO] 2020―Dec―03 Abstract PO-033: Professional and psychological impact of COVID-19 pandemic on medical and radiation oncology residents: Results of a national survey Marc Hilmi, Alice Boilève, Anabelle Ducousso, Morgan Michalet, Anthony Turpin, Cindy Neuzillet, Natacha Naoun
132 [GO] 2020―Dec―03 Abstract PO-023: Impact of the Covid-19 pandemic on medical oncology utilization at a busy urban academic medical center Sidharth Anand, Anne Walling, Neil Wenger, Katrina Fischer, Lisset Huerta-Cruz, Lisa Wilen, John Glaspy
133 [GO] 2020―Dec―03 Abstract PO-022: Impact of COVID-19 pandemic on new patient and consult visits at 20 hematology/oncology practices in the ASCO PracticeNET learning network Brian Bourbeau, Mou Guharoy, Elizabeth Garrett-Mayer, Stephen Grubbs, Paul Unger, Barbara McAneny, Richard L. Schilsky
134 [GO] 2020―Dec―03 Abstract PO-073: Effect of the COVID-19 pandemic on oncologists’ online CME consumption and educational needs Michelle A. Worst, Katie Lucero
135 [GO] 2020―Dec―03 Abstract PO-017: Evaluating the impact of the coronavirus (COVID-19) pandemic on treatment paradigms in head and neck cancer at a tertiary care hospital Joshua A. Thompson, Reju Joy, Joshua E. Lubek, Ranee Mehra, Jason K. Molitoris, Rodney J. Taylor, et al. (+3)
136 [GO] 2020―Dec―03 Abstract PO-088: COVID-19 pandemic slows launch of oncology clinical trials Elizabeth B. Lamont, Sheila S. Diamond, Ron G. Katriel, Jingshu Lui, Lisa Ensign, Caleb Alexander
137 [GO] 2020―Dec―03 Abstract PO-003: Early detection of breast cancer during the Covid-19 pandemic using artificial intelligence neural networks Subash Kumar
138 [GO] 2020―Dec―03 Abstract PO-038: Strong decline of newly diagnosed gynecologic and breast cancers during the COVID-19 pandemic: A retrospective analysis from Innsbruck, Austria Irina Tsibulak, Elisabeth Reiser, Christoph Ebner, Katharina Knoll, Katharina Leitner, Verena Wieser, et al. (+2)
139 [GO] 2020―Dec―03 Abstract PO-080: Increasing of emergency presentation on colorectal cancer patients during COVID-19 pandemic: A retrospective study on single-center academic hospital Budhi Ida Bagus, Metria Ida Bagus, Setyawati Ida Ayu, Mastini Ida Ayu Kade
140 [GO] 2020―Dec―03 Abstract PO-074: Patient concerns during the COVID-19 pandemic: Lessons from the lung cancer community Janet Freeman-Daily, Upal Basu Roy, Kim Norris, Becky Bunn, Jan Baranski, Cristina Chin, Amy C. Moore
141 [GO] 2020―Dec―03 Abstract PO-037: SKCC medical oncology telehealth experience during Covid-19 pandemic: Lessons learned and operational changes to leverage telehealth to maintain patient access Avnish Bhatia, Lauren Waldman, Gregory Garber, Megan Sabonjian, Melissa Hunt, Janene Palidora, et al. (+2)
142 [GO] 2020―Dec―03 Abstract PO-052: COVID-19 pandemic: Patients’ perspective during cancer treatment Filippo Merloni, Nicoletta Ranallo, Lucia Bastianelli, Francesca Vitarelli, Luca Cantini, Zelmira Ballatore, et al. (+13)
143 [GO] 2020―Dec―03 Abstract PO-076: Training and information during COVID-19 pandemic: The masterpiece in young oncologists Nicoletta Ranallo, Lucia Bastianelli, Filippo Merloni, Luca Cantini, Giulia Ricci, Zelmira Ballatore, Rossana Berardi
144 [GO] 2020―Dec―03 Abstract PO-034: Prospective planning of radiation treatment at new patient conference during the COVID-19 Pandemic: The University of Mississippi Medical Center experience Sanjay Joseph, Mary Nittala, Paul Roberts, Maurice King, Hiba Ahmed, Ashley Albert, et al. (+5)
145 [GO] 2020―Dec―03 Abstract S05-01: Profound CD8 T-cell responses towards SARS-CoV-2 OFR1ab in COVID-19 patients Anastasia Gangaev, Steven L. Ketelaars, Sanne Patiwael, Anna Dopler, Olga I. Isaeva, Kelly Hoefakker, et al. (+13)
146 [GO] 2020―Dec―03 Abstract PO-068: Efforts to define biochemical and pharmacologic pathways potentially beneficial to both cancer and COVID-19 patients Ugo Rovigatti, Amedeo Vannacci, Simone Del Corto, Ignacio Martin-Loeches, Andrea Piccin, Nizar Naji, Carmel Mothersill
147 [GO] 2020―Dec―03 Abstract PO-050: Computational modeling of immunologic response to immune checkpoint inhibitors in COVID-19 patients with and without cancer Giulia Russo, Luca Falzone, Bruno Cacopardo, Giuseppe Nunnari, Francesco Torino, Giuseppa Scandurra, et al. (+3)
148 [GO] 2020―Dec―03 Abstract S12-02: Risk of morbidity and mortality in COVID-19 patients with cancer Naomi Alpert, Bridget Marcellino, Joseph Rapp, Wil Lieberman-Cribbin, Emanuela Taioli
149 [GO] 2020―Dec―03 Abstract PO-063: Impact of cancer history on outcomes among hospitalized COVID-19 patients: A case-control analysis Isaac Klein, Shoshana Rosenberg, Camille Kotton, Kerry Reynolds, Leyre Zubiri, Rachel Gaither, et al. (+8)
150 [GO] 2020―Dec―03 Abstract PO-093: Low-dose whole-lung radiation for COVID-19 pneumonia: Planned day-7 interim analysis of a registered clinical trial Clayton B. Hess, Zachary S. Buchwald, William Stokes, Tahseen H. Nasti, Jeffrey M. Switchenko, Brent D. Weinberg, et al. (+6)
151 [GO] 2020―Dec―03 Abstract S05-02: COVIDOSE: Low-dose tocilizumab in the treatment of COVID-19 pneumonitis Garth W. Strohbehn, Brian L. Heiss, Sherin J. Rouhani, Jonathan A. Trujillo, Athalia R. Pyzer, Jovian Yu, et al. (+17)
152 [GO] 2020―Dec―03 Abstract PO-057: Cancer center support for understanding statewide COVID-19 prevalence and early detection Jackilen Shannon, David Bangsberg, Paul Spellman, Bridget Barnes, Jenny Lee Berry, Kim Brown, et al. (+6)
153 [GO] 2020―Dec―03 Abstract IA13: Treatment of COVID-19 pulmonary failure by targeting BTK Steven Peter Treon
154 [GO] 2020―Dec―03 Abstract S10-01: COVID-19 severity and outcomes in hospitalized patients with cancer at a New York City tertiary medical center: A matched cohort study Gagandeep Brar, Laura C. Pinheiro, Michael Shusterman, Brandon Swed, Evgeniya Reshentnyak, Orysya Soroka, et al. (+7)
155 [GO] 2020―Dec―03 Abstract PO-029: Operationalizing a prioritized COVID-19 testing strategy at a Canadian tertiary care cancer center April A. Hildebrand, Desiree Hao, Safiya Karim, Winson Y. Cheung, Don Morris, Daniel Y. C. Heng
156 [GO] 2020―Dec―03 Abstract S02-02: Covid-19 treatment candidate hydroxychloroquine impairs tumor response to anti-PD1 Simon Wabitsch, Jack C McVey, Chi Ma, Benjamin Ruf, Laurence Diggs, Bernd Heinrich, Tim F Greten
157 [GO] 2020―Dec―03 Abstract S01-02: Optimizing treatment for COVID-19 using computational modeling: Implications for cancer patients Chrysovalantis Voutouri, Mohammadreza Nikmaneshi, Melin Khandekar, Ankit B. Patel, Ashish Verma, Sayon Dutta, et al. (+3)
158 [GO] 2020―Dec―03 Abstract PO-046: Assessment of COVID-19 vaccine candidates: Prediction and validation of 174 SARS-CoV-2 epitopes Marek Prachar, Sune Justesen, Daniel Bisgaard Steen-Jensen, Stephan Thorgrimsen, Erik Jurgons, Ole Winther, Frederik Otzen Bagger
159 [GO] 2020―Dec―03 Abstract PO-026: Minimize impact of pandemic on radiation oncology department: Experience from a moderate-sized regional cancer program in the battle against COVID-19 virus Ming Pan, Khalid Hirmiz, Junaid Yousuf, Kitty Huang, Colvin Springer, Ken Schneider, Laura D’Alimonte
160 [GO] 2020―Dec―03 Abstract IA09: A phase II trial to promote recovery from COVID-19 with endocrine therapy Catherine H. Marshall, Srinivasan Yegnasubramanian, Hao Wang, Jennifer Durham, Ting Wang, Rachel Damico, et al. (+8)
161 [GO] 2020―Dec―03 Abstract PO-002: RUXCOVID: A phase 3, randomized, placebo-controlled study evaluating the efficacy and safety of ruxolitinib in patients with COVID-19-associated cytokine storm MeiLan K. Han, Rachel Ann Bender Ignacio, Amparo Lopez Bernus, Katrin Milger-Kneidinger, Amesika N. Nyaku, Ben Parker, et al. (+6)
162 [GO] 2020―Dec―03 Abstract PO-085: Sex bias in COVID-19-associated Illness severity and mortality in cancer patients: A systematic review and meta-analysis Robin Park, Anusha Chidharla, Kathan Mehta, Weijing Sun, Anup Kasi
163 [GO] 2020―Dec―03 Abstract S10-03: Increased risk of COVID-19-related death among cancer survivors Jie Shen, Hua Zhao
164 [GO] 2020―Dec―03 Abstract PO-082: Preliminary analysis of factors associated with COVID-19-related disease severity in cancer patients: University of Kansas Cancer Center experience Anup Kasi, Elizabeth Wulf-Burchfield, Natalie Streeter, Stephen Jackson, David Streeter, Eric Crowder, et al. (+2)
165 [GO] 2020―Dec―03 Abstract S07-04: Impact of COVID-19-related psychosocial distress on health-related quality of life in rural cancer survivors Scherezade K. Mama, Michelle Cardel, Kathryn H. Schmitz
166 [GO] 2020―Dec―03 Abstract PO-083: Prostate cancer and COVID-19: Impact of hormonal therapy on severe outcomes Karine Tawagi, Jeff Burton, Diana Maslov, Michael Lunski, Marc Matrana, Daniel Johnson
167 [GO] 2020―Dec―03 Abstract PO-045: Multiplex analysis of coronavirus and influenza antibodies using the ZIVA multiplex platform Jon Schmuke, Ben Miller, Linda Meeh, Byran Witherbee
168 [GO] 2020―Dec―03 Abstract S06-03: Cancer care telehealth utilization rates and provider attitudes in the wake of the novel coronavirus pandemic: The Kaiser Permanente Northern California experience Elad Neeman, Tatjana Kolevska, Mary Reed, Tilak Sundaresan, Amit Arora, Yan Li, et al. (+6)
169 [GO] 2020―Dec―03 Abstract S03-01: Pan-HLA prediction of SARS-CoV-2 epitopes Katie M. Campbell, Gabriela Steiner, Daniel K. Wells, Antoni Ribas, Anusha Kalbasi
170 [GO] 2020―Dec―03 Abstract PO-004: A double-edged sword: Prolonged detection of SARS-COV-2 in patients receiving cancer-directed therapy Winston Wong, Claire Brevia, Michael May, Susan Whittier, Eldad Hod, Ilenia Pellicciotta, et al. (+3)
171 [GO] 2020―Dec―03 Abstract S02-03: SARS-CoV-2 induces inflammatory cytokine release, which may be exacerbated by immune checkpoint blockade Layne Weatherford, Maria Lehn, McKenzie Crist, Chelsea Wendling, Kristin Hudock, Vinita Takiar, Trisha Wise-Draper
172 [GO] 2020―Dec―03 Abstract S09-02: Outcomes by race for cancer patients hospitalized with SARS-CoV-2 infection Steven S. Chang, Clara Hwang, Mohamed A. Elshaikh, Amy Tang, Christine M. Neslund-Dudas, Albert M. Levin, et al. (+2)
173 [GO] 2020―Dec―03 Abstract S04-02: Treatment with tocilizumab does not inhibit induction of anti-COVID-19 antibodies in patients with severe SARS-CoV-2 infection Alexandra Cabanov, Blake A. Flood, Jeffrey Bloodworth, Emily F. Higgs, Jessica Fessler, Michael Y.K. Leung, et al. (+12)
174 [GO] 2020―Dec―03 Abstract S01-03: A prediction of prostate cancer deaths spiking by SARS-CoV-2 infection Alakesh Bera, Eric Russ, Digonto Chatterjee, John Karaian, Madhan Subramanian, Sreejato Chatterjee, et al. (+4)
175 [GO] 2020―Dec―03 Abstract IA03: Systems approaches reveal shared pathways affected in SARS-CoV-2 infection and cancer Nevan Krogan
176 [GO] 2020―Dec―03 Abstract PO-024: Incidence of SARS-COV-2 infection in cancer patients undergoing active treatment Celia Martin Bravo, Isabel Blancas López-Barajas, Raúl Quirós López, Marta Robles Lasarte, Rosa Villatoro Roldán, Julia Alcaide García, et al. (+10)
177 [GO] 2020―Dec―03 Abstract S05-03: Preserving innate memory to overcome SARS-CoV-2 infection through the mevalonate pathway Juan Luis Gomez, Adam Brufsky
178 [GO] 2020―Dec―03 Abstract PO-049: SARS-CoV-2 multiepitope vaccine constructs designed to drive long-term immunity in the majority of the population Mark Yarmarkovich, John M. Warrington, Alvin Farrel, John M. Maris
179 [GO] 2020―Dec―03 Abstract PO-075: Performance comparison of five extraction kits for SARS-CoV-2 RNA extraction Ilinca M. Lungu, Angela De Luca, Jason Li, Jane Bayani, Melanie Spears, Trevor J. Pugh, John M.S. Bartlett
180 [GO] 2020―Dec―03 Abstract S08-01: Highly sensitive and full-genome interrogation of SARS-CoV-2 using multiplexed PCR enrichment followed by next-generation sequencing Chenyu Li, David N. Debruyne, Julia Spencer, Vidushi Kapoor, Lily Y. Liu, Bo Zhou, et al. (+19)
181 [GO] 2020―Dec―03 Abstract S03-03: A computational approach to identify a possible SARS-CoV-2 vaccine from receptor binding domain peptide sequence on spike glycoproteins Majid Al-Zahrani
182 [GO] 2020―Dec―03 Abstract S03-02: Sequence-based prediction of SARS-CoV-2 vaccine targets using a mass spectrometry-based bioinformatics predictor identifies immunogenic T-cell epitopes Asaf Poran, Dewi Harjanto, Matt Malloy, Christina M. Arieta, Daniel A. Rothenberg, Divya Lenkala, et al. (+5)
183 [GO] 2020―Dec―03 Abstract PO-043: A prospective testing SARS-Cov-2/COVID-19 in cancer patients with antitumor treatment Kathan D. Mehta, Elizabeth Wulf-Burchfield, Natalie Streeter, Anup Kasi, Adam H. AlDouri, Roy Jensen, et al. (+3)
184 [GO] 2020―Dec―03 Abstract PO-018: Hematology oncology COllaborative VIDeoconferencing (COVID) Learning Initiative: A multi-institutional trainee alliance to rapidly disseminate emerging SARS-CoV2 and cancer best practices Richard L. Martin, Michael Grant, Rushad Patell, Shonali Middha, Jori May, Charles Bodine, et al. (+7)
185 [GO] 2020―Dec―03 Abstract S07-03: Scientia potentia est: How the Italian world of oncology changes in the COVID19 pandemic Zelmira Ballatore, Lucia Bastianelli, Filippo Merloni, Nicoletta Ranallo, Luca Cantini, Lorenzo Mariotti, et al. (+4)
186 [GO] 2020―Dec―03 Abstract PO-006: Barriers to Virtual Video Connect (VVC) cancer care among southern rural veterans during the COVID19 pandemic Philip A. Haddad, Dalia Hammoud, Michelle Phelan, Rosline Wallace-Seamster, Kevin Gallagher
187 [GO] 2020―Dec―03 Abstract PO-039: Technology-mediated communication with patients is a challenge for oncologists in the digital and pandemic era… and the winner is WhatsApp! Mariangela Torniai, Giulia Marcantognini, Ilaria Fiordoliva, Giulia Mentrasti, Veronica Agostinelli, Alessandra Pagliacci, et al. (+2)
188 [GO] 2020―Dec―03 Abstract PO-072: Doctors and nurses during COVID19 pandemic: A different perception of cancer care Lucia Bastianelli, Filippo Merloni, Nicoletta Ranallo, Luca Cantini, Lorenzo Mariotti, Alessandra Lucarelli, et al. (+2)
189 [GO] 2020―Dec―03 Abstract PO-010: Changes in lung cancer treatment as a result of the COVID19 pandemic: A prospective observational study Suzanne Kazandjian, Nathaniel Bouganim, Arielle Elkrief
190 [GO] 2020―Oct―13 Similarities in Risk for COVID-19 and Cancer Disparities Lisa Newman, Robert A Winn, John M. Carethers
191 [GO] 2020―Aug―18 The Paradoxical Effects of COVID-19 on Cancer Care: Current Context and Potential Lasting Impacts Alex Broom, Katherine Kenny, Alexander Page, Nicole Cort, Eric Lipp, Aaron C Tan, et al. (+3)
192 [GO] 2020―Jul―02 COVID-19 testing in cancer patients: Does one size fit all? Ainhoa Madariaga, Michelle McMullen, Semira Sheikh, Rajat Kumar, Fei-Fei Liu, Camilla Zimmermann, et al. (+3)
193 [GO] 2020―Jun―15 Immune-Checkpoint Inhibitors for Cancer Therapy in the COVID-19 Era Michele Maio, Omid Hamid, James Larkin, Alessia Covre, Maresa Altomonte, Luana Calabrò, et al. (+6)
194 [GO] 2020―Jun―05 The World of Clinical Trial Development Post-Covid-19: Lessons Learned from a Global Pandemic. Fatima Karzai, Ravi A. Madan, William Dahut
195 [GO] 2020―Apr―20 Adapting to a pandemic - conducting oncology trials during the SARS-CoV-2 pandemic Aaron C Tan, David M Ashley, Mustafa Khasraw
 [1] 

195 Results       Page 1


[de][en]

Last change 2023―Oct―27 12:08:13 UTC

© Daten-Quadrat 2022       Done in 0.005 sec